Key result
Betamethasone reduces clearance by ~36% and persists longer compared with dexamethasone.
Why the study?
Pharmacokinetic data for different dosage forms and routes of dexamethasone and betamethasone in Indian women were analyzed to characterize absorption and disposition parameters.
RCT (n=48)
Open-label
Randomized into eight sequences
No
Betamethasone has slower clearance, larger volume of distribution, and longer half-life compared to dexamethasone, which may inform dosing when substituting these corticosteroids.
Answers are grounded in this paper and cite their sources.
Provides first population PK estimates for DEX/BET formulations in Indian women; leaves open generalizability to pregnancy or other groups.
Population analysis of pharmacokinetic data for five differing dosage forms and routes for dexamethasone and betamethasone in 48 healthy nonpregnant Indian women was performed that accounted for a partial and complex cross-over design. Single doses of 6 mg dexamethasone phosphate (DEX-P), betamethasone phosphate (BET-P), or 1:1 mixture of betamethasone phosphate and acetate (BET-PA) were administered orally (PO) or intramuscularly (IM). Plasma concentrations collected for two periods over 96 h were described with a two-compartment model with differing PO and IM first-order absorption inputs. Clearances and volumes were divided by the IM bioavailability FIM F IM . The homogeneous ages, body weights, and ethnicity of the women obviated covariate analysis. Parameter estimates were obtained by the Laplace estimation method implemented in NONMEM 7.4. Typical values for dexamethasone were clearance ( CL/FIM) C L / F IM ) of 9.29 L/h, steady-state volume ( Vₛₛ/FIM) V ss / F IM ) of 56.4 L, IM absorption constant (kaIM) k aIM of 0.460 1/h and oral absorption constant ( kaPO) k aPO ) of 0.936 1/h. Betamethasone parameters were CL/FIM of 5.95 L/h, Vss/FIM V s s / F IM of 72.4 L, kaIM k aIM of 0.971 1/h, and kaPO k aPO of 1.21 1/h. The PO to IM F values were close to 1.0 for both drugs. The terminal half-lives averaged about 7.5 h for DEX, 17 h for BET, and 78 h for BET from BET-PA with the latter reflecting very slow release of BET from the acetate ester. Overall, BET exhibited slower clearance, larger volume of distribution, faster absorption, and longer persistence than DEX. These data may be useful in considering exposures when substituting one form of corticosteroid for another.
No takes yet. Share an insight, caveat, or question.
Krzyżański et al. (2021) conducted an RCT in Healthy nonpregnant women (n=48). Dexamethasone and Betamethasone vs. Cross-over comparisons between formulations and routes was evaluated on Population pharmacokinetic parameters (Clearance, Volume of distribution, absorption constants). Betamethasone exhibited slower clearance, larger volume of distribution, faster absorption, and longer persistence than dexamethasone.
Synapse has enriched 10 related papers. Consider them for comparative context: